Precipio Competitors and Similar CompaniesClear all

Precipio's competitors and similar companies include nRichDX and MDxHealth.
Precipio
Precipio
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
nRichDX
nRichDX
nRichDX is a biotech company providing liquid biopsy sample preparation for molecular testing.
MDxHealth
MDxHealth
MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.
Founding Date
Founding Date
1997
Founding Date
N/A
Founding Date
2003
Type
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Omaha, US HQ
Glasgow, GB
New Haven, US
Omaha, US
Locations
Irvine, US HQ
Locations
Herstal, BE HQ
Nijmegen, NL
Irvine, US
Plano, US
Employees
Employees
4235% increase
Employees
18
Employees
252
Valuation ($)
Valuation ($)
9.3 m
Valuation ($)
N/A
Valuation ($)
93.5 m

Financial

Revenue (est.)
Revenue (est.)
$24m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$107.9m (FY, 2025)
Cost of goods
Cost of goods
$13.3m (FY, 2025)
Cost of goods
N/A
Cost of goods
$36.1m (FY, 2025)
Gross profit
Gross profit
$10.7m (FY, 2025)
Gross profit
N/A
Gross profit
$71.8m (FY, 2025)
Net income
Net income
($363k) (FY, 2025)
Net income
N/A
Net income
($33.5m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 1.5m
Total funding raised
N/A
Total funding raised
$ 1.1m
For sources of this data, please see the company profile

View Company Profiles

nRichDX
HQ
Irvine, US
Employees
18

nRichDX is a biotech company providing liquid biopsy sample preparation for molecular testing.

View company
MDxHealth
HQ
Herstal, BE
Employees
252

MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.

View company